IMC research team supports market insight with information delivery across therapies, treatments and regulatory parameters. We investigate drugs through stages of clinical developments in the field of oncology, cardiology, gastroenterology, surgery, immunology, endocrinology etc.
This research helps Defined Health recommendations of potential drugs to fit into client's therapeutic strategy, helps in identifying compounds in development or on market to fill a pipeline gap or meet revenue goals in the future of companies. The company recommends therapeutic areas for clients investment, whether to acquire or fund the company and how much to be invested for a ceaseless growth.
